Supplementary Fig. 4 from Targeting the ERα DBD–LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation
Abstract
Supplementary Fig. 4: Evaluation of combination treatment effects between MTO and established ER antagonists in MCF7 cells
Fields of Study & Subjects
Melanoma and MAPK Pathways
Endoplasmic Reticulum Stress and Disease
Protein Kinase Regulation and GTPase Signaling
Publication details
- Publication date
- 2 January 2026